Physician profile
Kimberly K Crowell
NPI 1164744090
$1,989.79
in general payments reported to CMS, 2019-2025
16 companies · $389 in 2025
The $389 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $94.46 · 2022: $805 · 2023: $476 · 2024: $225 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,090.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,545.62 | 2022-2025 | Wavewriter Alpha Prime 16, Patient Trial Kit, Freelink |
| Pacira Pharmaceuticals Incorporated | $78.00 | 2023-2024 | Zilretta, Iovera |
| Hikma Pharmaceuticals USA | $51.73 | 2022 | |
| Collegium Pharmaceutical, INC. | $44.47 | 2022-2024 | Belbuca |
| Biotissue Holdings INC. | $42.14 | 2025 | |
| Si-Bone, INC. | $37.46 | 2022-2025 | |
| Spinal Simplicity, LLC | $33.92 | 2024 | Ha Minuteman G3-R |
| Scilex Pharmaceuticals INC. | $21.87 | 2021 | |
| Welch Allyn | $21.60 | 2021 | |
| Reprise Biomedical, INC. | $21.44 | 2025 | Miro 3d |
| Medtronic, INC. | $18.93 | 2021 | |
| Biodelivery Sciences International, INC. | $18.13 | 2021 | |
| Abbott Laboratories | $16.20 | 2022 | |
| Redhill Biopharma INC. | $13.93 | 2021 | |
| Tersera Therapeutics LLC | $12.86 | 2023 | Prialt |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $11.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Crowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.